New evidence-based approach will help bolster VMD's work.
The National Office of Animal Health Limited (NOAH) has shown support for the new Regulatory Science Strategy outlined by the Veterinary Medicines Directorate (VMD).
The Strategy Vision is: “To promote the scientific basis underlying the authorisation and regulation of veterinary medicines, ensuring the availability of products which support animal health whilst protecting public health and the environment.”
It aims to ensure that the VMD remains informed on future technological advances and new approaches, so that it can be prepares to address scientific and regulatory challenges that may arise.
In a statement NOAH praised this commitment to an evidence-based approach, calling it a positive step forward which will help secure a future for development, authorisation and regulation of veterinary medicines in the UK based on a rational and flexible regulatory platform.
NOAH chief executive Dawn Howard said: “We provided feedback on the objectives and strategic goals of the strategy followed by key points our sector consider to be important in the upcoming review of the Veterinary Medicines Regulations, an important instrument to support the VMD Regulatory Science Strategy.
“Execution of this strategy will be a long-term objective and we have stressed that it will be important that VMD continues to consult with stakeholders regularly and proactively. NOAH would welcome more dialogue on this in the future as plans evolve.’’
To view the draft Regulatory Science Strategy please click here.
FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.
